CN1642525A - 无水化合物的hfa混悬剂 - Google Patents

无水化合物的hfa混悬剂 Download PDF

Info

Publication number
CN1642525A
CN1642525A CNA038072475A CN03807247A CN1642525A CN 1642525 A CN1642525 A CN 1642525A CN A038072475 A CNA038072475 A CN A038072475A CN 03807247 A CN03807247 A CN 03807247A CN 1642525 A CN1642525 A CN 1642525A
Authority
CN
China
Prior art keywords
suspensoid
acid
tiotropium
impelling
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038072475A
Other languages
English (en)
Chinese (zh)
Inventor
克里斯特尔·施梅尔泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of CN1642525A publication Critical patent/CN1642525A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CNA038072475A 2002-03-28 2003-03-20 无水化合物的hfa混悬剂 Pending CN1642525A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264.5 2002-03-28
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats

Publications (1)

Publication Number Publication Date
CN1642525A true CN1642525A (zh) 2005-07-20

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038072475A Pending CN1642525A (zh) 2002-03-28 2003-03-20 无水化合物的hfa混悬剂

Country Status (21)

Country Link
EP (1) EP1492498A2 (ja)
JP (1) JP5147158B2 (ja)
KR (1) KR101005717B1 (ja)
CN (1) CN1642525A (ja)
AU (1) AU2003221509B2 (ja)
BR (1) BR0308709A (ja)
CA (1) CA2479638C (ja)
DE (1) DE10214264A1 (ja)
EA (1) EA008610B1 (ja)
EC (1) ECSP045322A (ja)
HR (1) HRP20040890A2 (ja)
IL (1) IL163696A0 (ja)
ME (1) ME00246B (ja)
MX (1) MXPA04009338A (ja)
NO (1) NO20044004L (ja)
NZ (1) NZ536030A (ja)
PL (1) PL371295A1 (ja)
RS (1) RS52481B (ja)
UA (1) UA79776C2 (ja)
WO (1) WO2003082244A2 (ja)
ZA (1) ZA200405637B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102753152A (zh) * 2009-05-29 2012-10-24 珍珠治疗公司 活性剂的呼吸递送
CN115252552A (zh) * 2016-09-19 2022-11-01 墨西哥氟石股份公司 药物组合物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2606549A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
KR20080007656A (ko) * 2005-05-02 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 티오트로피움 브로마이드의 신규한 결정질 형태
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6475467B1 (en) * 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
EP1341538B1 (de) * 2000-10-31 2009-12-23 Boehringer Ingelheim Pharma GmbH & Co.KG Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102753152A (zh) * 2009-05-29 2012-10-24 珍珠治疗公司 活性剂的呼吸递送
CN102753152B (zh) * 2009-05-29 2015-09-23 珍珠治疗公司 活性剂的呼吸递送
CN115252552A (zh) * 2016-09-19 2022-11-01 墨西哥氟石股份公司 药物组合物

Also Published As

Publication number Publication date
KR20040098022A (ko) 2004-11-18
PL371295A1 (en) 2005-06-13
EA008610B1 (ru) 2007-06-29
KR101005717B1 (ko) 2011-01-05
DE10214264A1 (de) 2003-10-16
WO2003082244A3 (de) 2004-02-05
JP5147158B2 (ja) 2013-02-20
EP1492498A2 (de) 2005-01-05
EA200401159A1 (ru) 2005-04-28
ECSP045322A (es) 2005-01-28
CA2479638A1 (en) 2003-10-09
BR0308709A (pt) 2005-01-04
CA2479638C (en) 2011-01-04
WO2003082244A2 (de) 2003-10-09
YU86004A (sh) 2006-08-17
AU2003221509B2 (en) 2008-01-24
JP2005527550A (ja) 2005-09-15
NZ536030A (en) 2006-07-28
UA79776C2 (en) 2007-07-25
HRP20040890A2 (en) 2005-06-30
ME00246B (me) 2011-05-10
IL163696A0 (en) 2005-12-18
NO20044004L (no) 2004-10-05
MXPA04009338A (es) 2005-01-25
RS52481B (en) 2013-02-28
MEP47308A (en) 2011-02-10
AU2003221509A1 (en) 2003-10-13
ZA200405637B (en) 2005-07-27

Similar Documents

Publication Publication Date Title
CN1221549C (zh) 结晶单水合物、其制备方法及其在制备药物组合中的用途
CN1210017C (zh) 含噻托品鎓的新颖可吸入粉末
CN1269470C (zh) 制备粉末制剂的方法
JP2005504015A (ja) 抗コリン作用薬、その製造方法及び医薬組成物を製造するためのその使用
JP4554936B2 (ja) Ｍ３アンタゴニストとしてのトロペノール及びスコピンのキサンテンカルボン酸エステル、その製造方法及び薬物としてのその使用
RU2325388C2 (ru) Новые антихолинергические средства, способ их получения, а также их применение в качестве лекарственных средств
US7736627B2 (en) HFA suspension formulations containing an anticholinergic
CN1852713A (zh) 孟鲁司特钠的多晶型
CN1642525A (zh) 无水化合物的hfa混悬剂
CN1642534A (zh) 含有抗胆碱能药的hfa－混悬剂
CN1205182C (zh) 甲磺司特晶体
US7244415B2 (en) HFA suspension formulations of an anhydrate
TWI465416B (zh) 胺甲酸酯立體異構物
JP4589006B2 (ja) ムスカリン様ｍ３受容体の拮抗薬としてのヒドロキシ置換窒素複素環の新規エステル、その調製法並びに製薬組成物としてのその使用
CN101052388A (zh) 含有拟β肾上腺素能剂和抗胆碱能剂的药物组合物
CN1646099A (zh) 适于吸入的粉末制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1079093

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1079093

Country of ref document: HK